Poison Pill is a medical thriller that follows Dr. Mark Lin, a hospital internist in Southern California, after two young patients land in his care with problems that feel too extreme, too early: a 24-year-old in kidney failure and a severely obese man with worsening breathing issues. When Mark notices a common thread, both men have been using weight-loss products, one an herbal supplement called Motileaf and the other a prescription drug called Naxipil, his curiosity turns into an off-the-clock investigation that pulls him from hospital rounds into supplement shops, corporate hallways, and a much bigger fight over how “help” gets sold, regulated, and sometimes weaponized.

What I liked right away is how the book opens with the body, not the conspiracy. There’s this clear-eyed attention to blood, organs, and the quiet terror of hearing a patient ask if they’re going to die. The medical detail is frequent and confident, but it usually lands in a way that serves the tension instead of showing off. You can almost smell the dialysis unit and feel the fluorescent stillness of a hospital hallway. And the first-person voice works here. Mark can be compassionate with patients, prickly with colleagues, and blunt in his private thoughts, sometimes all in the same scene. That mix made him feel authentic to me, which matters in a genre where the lead can easily turn into a walking lab coat.

Author Anthony Lee also makes a deliberate choice to bring the reader into the systems around medicine, not just the bedside moments. You get a lot about how herbal supplements slide through looser oversight, how pharma messaging moves, and how “evidence” can be both a shield and a sales tool. The plot escalates the way good thrillers do: one unsettling link becomes two, then suddenly Mark is watching the supply chain and realizing how many hands touch a “simple” capsule before it reaches someone’s kitchen counter. The story occasionally pauses to explain processes and terminology, which will work for some readers, but I found it mostly grounded because it’s framed as how a clinician thinks when the pattern won’t let go.

Poison Pill reminds me of author Tess Gerritsen, where the pace comes from a doctor pushing past polite boundaries because the official story does not add up, like in Harvest. And if you like Michael Crichton’s “this could actually happen” vibe, especially the procedural, systems-focused suspense of The Andromeda Strain, Lee’s interest in process, oversight, and unintended consequences will feel familiar, just grounded more in everyday medicine and consumer health than in big sci-fi set pieces.

I’d recommend Poison Pill to readers who like medical thrillers with a strong “how did this happen” spine, especially if you enjoy stories that blend clinical realism with corporate and regulatory pressure. If you’re into slow-burn unease that builds into a wider conspiracy, and you don’t mind learning a little along the way, this one will hit the spot.

Pages: 383 | ASIN ‏ : ‎ B0GGZG155T